Drug Page

Recently, major researchers, including David Healy, Jon Juriedini, Mickey Nardo, and their colleagues, have brought a great deal of attention to issues of corruption...

A fist of its kind neuroscience study, published this month in Cerebral Cortex, found changes in the brain electrical activity of infants exposed to SSRI antidepressants during pregnancy.

Many experts expressed concern when the rate of antipsychotic prescriptions to children in foster care showed a rapid increase, peaking in 2008, and new recommendations and policies have tried to curb the use of these drugs. While the rate has plateaued, a new study points out that the “new normal” prescription levels are still dangerously high. The data reveals that almost one in ten children in foster care are currently being prescribed antipsychotic drugs with dangerous side-effects, many for diagnoses like ‘ADHD’ and disruptive behavior.

In December, MIA  reported on a systematic Cochrane review on the research for the safety and effectiveness of Ritalin (methylphenidate) that found substantial bias...

As part of NBC's 'On Assignment' series reporter Kate Snow took a closer look at the prescribing of antipsychotic drugs "off-label" to children. The...

In a large review study published this week in The Lancet, researchers assessed the effectiveness and potential harms of fourteen different antidepressants for their use in children and adolescents. The negative results, familiar to MIA readers, are now making major headlines.

This Sunday, June 12 at 7pm (EDT) on NBCs Dateline will cover MIA author Steve Francesco's book, Overmedicated and Undertreated: How I Lost My...

Our headline on an Around the Web item posted on June 8 stating that the former head of the FDA, Margaret Hamburg, had been "charged"...

Antidepressant use during pregnancy has been associated with a number of fetal and developmental complications. The latest meta-analysis of the effect of SSRI antidepressants...

For STAT, Meghana Kashavan reports on a new, candy-flavored, chewable, fruity, amphetamine drug on the market for children diagnosed with ADHD. “It’s a move...

In 2011 the American Academy of Pediatrics (AAP) issued guidelines recommending therapy over stimulant drugs as the primary treatment for children diagnosed with ‘ADHD.’ New research from the CDC reveals, however, that children between ages 2 and 5 are still being prescribed medications before receiving the recommended therapy or psychological services. Overall, the researchers found that 75% of these children are being prescribed “ADHD’ drugs while no more than 55% receive psychological treatments. Incredibly, among children on private insurances, the percentage of children receiving psychological services for ‘ADHD’ showed no increase following the 2011 recommendations.

In a review editorial for the journal Psychotherapy and Psychosomatics, neurobiology researcher Steven Dubovsky from the University at Buffalo argues against the adoption of...

Ed Silverman reports for STAT’s Pharmalot that high-ranking congressmen are accusing the Department of Health and Human Services of deliberately delaying new guidelines on...

Last week, reports circulated about a system through which drug companies used charitable giving for profit. Now, three drug manufacturers, Gilead Sciences Inc., Biogen...

A study published in the journal Pediatrics reveals large differences from one pediatrician to the next when it comes to diagnosing and prescribing drugs for ‘ADHD.’ The researchers found that the percentage of children being diagnosed with ‘ADHD’ varied from as high as 16% of patients at some offices to as little as 1% of patients at others. The data also revealed significant but lower variability in the pediatric diagnosis of anxiety and depression.

While an estimated 74-percent of patients diagnosed with major depression receive a prescription for an antidepressant, new research reveals that mindfulness-based cognitive therapy (MBCT)...

For the Conversation, Binghamton University researcher Lina Begdache tackles the issue of the growing use of 'Study Drugs' in the student population. “Animal studies show...

In a new article for Scientific American, Diana Kwon reports on how the true risks for suicide and aggression in children and teens taking...

The 11 July 2016 will be the inaugural World Benzodiazepine Awareness Day, part of a campaign to raise global awareness about the issue of doctor-induced benzodiazepine dependency, which affects...

According to new research, the United States spends over 200 billion annually on treatment and hospitalization for mental health issues, exceeding spending on heart...

The writings of Pies and his colleagues, I believe, provide a compelling case study of cognitive dissonance. Cognitive dissonance arises when people are presented with information that creates conflicted psychological states, challenging some belief they hold dear, and people typically resolve dissonant states by sifting through information in ways that protect their self-esteem and their financial interests. It is easy to see that process operating here.

The largest ever study of the thoughts and reactions of antidepressant users reveals that many people have vastly different understandings and experiences of the...

A groundbreaking article for The Province is “sounding the alarm over the heightened risk of death linked to the use of psychiatric drugs.” They report on...

In his “Mind the Brain” blog for PLOS, well-known researcher James Coyne reviews the controversy surrounding the latest case of a fraudulently reported study...

A systematic review published this week in the British Journal of Clinical Pharmacology found that patients taking antipsychotic drugs were at nearly twice the risk...